GLP-1 has shown remarkable benefits beyond glycemic control, particularly in weight management
Increased dosage dependency Over time, patients may require higher doses of GLP-1 medications, which can exacerbate common gastrointestinal side effects and make long-term management more challenging
Pineo G, Hull R, Marder V
Previous work has established that any residual OCR detected after oligomycin A treatment is due to non-respiratory oxygen consumption, which is usually ascribed to proton leakage through the mitochondrial inner membrane 79
Systemic Side Effects Gastrointestinal Side Effects The most commonly reported side effects of GLP-1 RAs are gastrointestinal, including nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspepsia [113,114,115]
En rsum, il pige les agents nfastes et contribue la protection de lorganisme